PERSONA® Vivacit-E® 42-5221-005-10Recalls & reported problems
Zimmer, Inc. · Class 2 · Implant
All models of PERSONA Vivacit-E (285)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00889024468177), received between Sep 30, 2019 and Nov 26, 2025 — classified as 5 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Device Contaminated During Manufacture or Shipping” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem5
- Device Contaminated During Manufacture or Shipping1
- Insufficient Device Problem Information1
- Use of Device Problem1
Patient problems
- Loss of Range of Motion3
- No Clinical Signs, Symptoms or Conditions2
- Fall1
- Hyperextension1
- Muscular Rigidity1
- Scar Tissue1
- Wound Dehiscence1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 26, 2025Device Contaminated During Manufacture or Shipping; Device Contaminated During Manufacture or Shipping
NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23658546 ↗InjuryJun 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.
Patient problems: Fall; Hyperextension; Wound Dehiscence
MAUDE report 22326987 ↗InjuryJun 19, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED VIA A CLINICAL STUDY THAT A PATIENT UNDERWENT AN INITIAL RIGHT TOTAL KNEE ARTHROPLASTY. SUBSEQUENTLY, APPROXIMATELY SIX (6) WEEKS POST-IMPLANTATION, THE PATIENT REQUIRED A MANIPULATION UNDER ANESTHESIA DUE TO STIFFNESS AND LIMITED FLEXION FROM NOT COMPLETING THE PRESCRIBED POSTOP THERAPY. THE PATIENT OUTCOME IS REPORTED AS IMPROVING.
Patient problems: Loss of Range of Motion
MAUDE report 19567066 ↗InjuryJun 1, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.
Patient problems: Muscular Rigidity
MAUDE report 17040278 ↗InjuryAug 4, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED PATIENT UNDERWENT A MANIPULATION UNDER ANESTHESIA APPROXIMATELY ELEVEN MONTHS POST IMPLANTATION DUE TO STIFFNESS AND ARTHROFIBROSIS.
Patient problems: Loss of Range of Motion; Scar Tissue
MAUDE report 15164183 ↗MalfunctionApr 20, 2022Use of Device Problem; Use of Device Problem
IT WAS REPORTED THAT THE PATIENT UNDERWENT AN INITIAL TOTAL KNEE REPLACEMENT. THE HOSPITAL IMPLANTED A WRONG SIZE INSERT, ONE THAT IS MEANT TO BE USED WITH A BIGGER FEMUR. THIS WAS DISCOVERED AFTER SURGERY. THE PATIENT WAS NOTED TO BE IN GOOD AND STABLE MOTION. ATTEMPTS HAVE BEEN MADE AND NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14161499 ↗InjurySep 30, 2019Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
A PATIENT ENROLLED IN A CLINICAL STUDY UNDERWENT RIGHT KNEE ARTHROPLASTY AND WAS NOTED TO HAVE STIFFNESS AND DECREASED RANGE OF MOTION DURING THEIR ONE MONTH FOLLOW-UP VISIT. PATIENT UNDERWENT A MANIPULATION UNDER ANESTHESIA APPROXIMATELY TWO WEEKS LATER AND AGAIN APPROXIMATELY ONE MONTH LATER. PATIENT CONTINUES TO HAVE PAIN AND STIFFNESS AS OF THE THREE MONTH FOLLOW UP.
Patient problems: Loss of Range of Motion
MAUDE report 9134990 ↗
Other Prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer + additive/metal/polymer + additive devices
- iTotal® PS TPS111111102Conformis, Inc. · Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer + Additive/Metal/Polymer + Additive327 reports
- ATTUNE 1506-00-006Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer + additive/metal/polymer + additive287 reports
- ATTUNE 1506-00-008Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer + additive/metal/polymer + additive233 reports
- iTotal® Cruciate Retaining (CR) Knee Replacement System TCR121111102Conformis, Inc. · Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer + Additive/Metal/Polymer + Additive150 reports
- ATTUNE 1506-70-007Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer + additive/metal/polymer + additive1 recall2 deaths74 reports
- ATTUNE 1516-40-506Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer + additive/metal/polymer + additive121 reports
- ATTUNE 1506-70-006Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer + additive/metal/polymer + additive1 recall70 reports
- ATTUNE 1516-40-605Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer + additive/metal/polymer + additive120 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page